Login / Signup

An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD).

Michele VaccaIoannis KamzolasLea Mørch HarderFiona OakleyChristian TrautweinMaximilian HattingTrenton RossBarbara BernardoAnouk OldenburgerSara Toftegaard HjulerIwona KsiazekDaniel LindénDetlef SchuppanSergio Rodriguez-CuencaMaria Manuela ToniniTamara R CastañedaAimo KanntCecília Maria Pereira RodriguesSimon CockellOlivier GovaereAnn K DalyMichael E D AllisonKristian Honnens de LichtenbergYong Ook KimAnna LindblomStephanie OldhamAnne-Christine AndréassonFranklin J SchlermanJonathon MarioneauxArun SanyalMarta B AfonsoRamy YounesYuichiro AmanoScott L FriedmanShuang WangDipankar BhattacharyaEric SimonValérie ParadisAlastair BurtIoanna-Maria GrypariSusan DaviesAnn DriessenHiroaki YashiroSusanne PorsMaja Worm AndersenMichael FeighCarla YunisPierre BedossaMichelle StewartHeather L CaterSara E WellsJörn Markus SchattenbergQuentin Mark Ansteenull nullDina TiniakosJames W PerfieldEvangelia PetsalakiPeter DavidsenAntonio Vidal-Puig
Published in: Nature metabolism (2024)
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease, encompasses steatosis and metabolic dysfunction-associated steatohepatitis (MASH), leading to cirrhosis and hepatocellular carcinoma. Preclinical MASLD research is mainly performed in rodents; however, the model that best recapitulates human disease is yet to be defined. We conducted a wide-ranging retrospective review (metabolic phenotype, liver histopathology, transcriptome benchmarked against humans) of murine models (mostly male) and ranked them using an unbiased MASLD 'human proximity score' to define their metabolic relevance and ability to induce MASH-fibrosis. Here, we show that Western diets align closely with human MASH; high cholesterol content, extended study duration and/or genetic manipulation of disease-promoting pathways are required to intensify liver damage and accelerate significant (F2+) fibrosis development. Choline-deficient models rapidly induce MASH-fibrosis while showing relatively poor translatability. Our ranking of commonly used MASLD models, based on their proximity to human MASLD, helps with the selection of appropriate in vivo models to accelerate preclinical research.
Keyphrases
  • endothelial cells
  • oxidative stress
  • pluripotent stem cells
  • gene expression
  • metabolic syndrome
  • insulin resistance
  • adipose tissue
  • skeletal muscle
  • dna methylation
  • mesenchymal stem cells
  • single cell